急性等容性血液稀释在动脉瘤性蛛网膜下腔出血夹闭术中的应用
ANH未减少围术期异体输血需求,但显著提高术后第1天和第3天血红蛋白水平,术后第1天血红蛋白是不良结局的独立危险因素。
要点
- ANH未减少aSAH夹闭术围术期异体输血需求(15% vs 11.9%,P=0.734)。
- ANH显著提高术后第1天(11.5±2.5 vs 10.3±2.0 g/dL,P=0.045)和第3天血红蛋白(12.1±2.0 vs 10.7±1.3 g/dL,P=0.002)。
- 术后第1天血红蛋白是不良结局独立危险因素(OR 0.895,95%CI 0.822-0.973,P=0.010)。
核心结论
- ANH显著提高aSAH夹闭术后血红蛋白水平,可能具有改善患者结局的潜力。
- 建议在动脉瘤夹闭术中考虑常规使用ANH。
研究设计与样本
- 纳入出血72小时内行夹闭术的aSAH患者,ANH组采集400mL自体血并按需回输,比较围术期异体输血、结局和并发症。
主要发现
- ANH未减少围术期异体输血需求(3[15%] vs 5[11.9%],P=0.734)。
- ANH显著提高术后第1天血红蛋白(11.5±2.5 g/dL vs 10.3±2.0 g/dL,P=0.045)和第3天血红蛋白(12.1±2.0 g/dL vs 10.7±1.3 g/dL,P=0.002)。
- 多因素分析显示术后第1天血红蛋白是不良结局独立危险因素(OR 0.895,95%CI 0.822-0.973,P=0.010)。
- ROC曲线分析显示术后第1天血红蛋白预测不良结局的能力与WFNS分级相当(Z=0.275,P>0.05)。
临床怎么用
- 在aSAH夹闭术中可考虑应用ANH以提升术后血红蛋白水平。
- 术后第1天血红蛋白水平可用于辅助评估不良结局风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The occurrence of coronavirus disease 2019 (COVID-19) has overwhelmed the blood supply chain worldwide and severely influenced clinical procedures with potential massive blood loss, such as clipping surgery for aneurysmal subarachnoid hemorrhage (aSAH). Whether acute normovolemic hemodilution (ANH) is safe and effective in aneurysm clipping remains largely unknown. METHODS: Patients with aSAH who underwent clipping surgery within 72 hours from bleeding were included. The patients in the ANH group received 400 mL autologous blood collection, and the blood was returned as needed during surgery. The relationships between ANH and perioperative allogeneic blood transfusion, postoperative outcome, and complications were analyzed. RESULTS: Sixty-two patients with aSAH were included between December 2019 and June 2020 (20 in the ANH group and 42 in the non-ANH group). ANH did not reduce the need of perioperative blood transfusion (3 [15%] vs. 5 [11.9%]; P = 0.734). However, ANH significantly increased serum hemoglobin levels on postoperative day 1 (11.5 ± 2.5 g/dL vs. 10.3 ± 2.0 g/dL; P = 0.045) and day 3 (12.1 ± 2.0 g/dL vs. 10.7 ± 1.3 g/dL; P = 0.002). Multivariable analysis indicated that serum hemoglobin level on postoperative day 1 (odds ratio, 0.895; 95% confidence interval, 0.822-0.973; P = 0.010) was an independent risk factor for unfavorable outcome, and receiver operating characteristic curve analysis showed that it had a comparable predictive power to World Federation of Neurosurgical Societies grade (Z = 0.275; P > 0.05). CONCLUSIONS: ANH significantly increased postoperative hemoglobin levels, and it may hold the potential to improve patients' outcomes. Routine use of ANH should be considered in aneurysm clipping surgery.
引用
- Chen P, Wang Y, Zhang XH, et al. The Use of Acute Normovolemic Hemodilution in Clipping Surgery for Aneurysmal Subarachnoid Hemorrhage. World Neurosurg. 2020. PMID: 33385596. doi:10.1016/j.wneu.2020.12.110
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。